Anti-Mouse EpCAM (CD326) [Clone G8.8] — Purified in vivo PLATINUMTM Functional Grade

Anti-Mouse EpCAM (CD326) [Clone G8.8] — Purified in vivo PLATINUMTM Functional Grade

Product No.: C725

- -
- -
Clone
G8.8
Target
CD326
Formats AvailableView All
Product Type
Hybridoma Monoclonal Antibody
Alternate Names
EGP314
Isotype
Rat IgG2a κ
Applications
FC
,
IF
,
IHC
,
IP
,
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Mouse
Host Species
Rat
Recommended Isotype Controls
Recommended Isotype Controls
Recommended Dilution Buffer
Immunogen
TE-71 thymic epithelial cell line
Product Concentration
≥ 5.0 mg/ml
Endotoxin Level
<0.5 EU/mg as determined by the LAL method
Purity
≥95% by SDS Page
≥98% monomer by analytical SEC
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
State of Matter
Liquid
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory Status
Research Use Only
Country of Origin
USA
Shipping
2-8°C Wet Ice
Additional Applications Reported In Literature ?
IHC,
IF,
FC,
IP,
WB
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
G8.8 activity is directed against mouse EpCAM (CD326) and does not recognize human or rat EpCAM.
Background
Epithelial cell adhesion molecule (EpCAM; also known as CD326 or Tacstd1) is a 40 kDa type I transmembrane glycoprotein composed of an extracellular domain, single transmembrane domain, and the intracellular domain Ep1CD1. EpCAM functions in cell adhesion, signaling, differentiation, migration, proliferation, formation and maintenance of organ morphology, and morphogenic movements during gastrulation. Additionally, EpCAM is essential for cell junctions; the AxxxG motif in the transmembrane domain of EpCAM associates directly with claudin-7, an important tight junction protein. EpCAM also suppresses or enhances E-cadherin function depending on the context of the interaction. Mutant animal models have been developed in mouse (at least four global EpCAM knockout types and one conditional knockout), zebrafish, and Xenopus.

Dysregulation and/or mutations are associated with congenital tufting enteropathy (CTE), which causes lethal diarrhea in newborns, cholestatic liver diseases, and cancer1. EpCAM promotes the proliferation of tumors, is involved in tumorigenesis and metastasis, and EpCAM positive cells serve as cancer stem cells for various human cancers. Therapeutic approaches targeting EpCAM are under development to eliminate chemotherapeutic drug resistance in cancer stem cells by conjugating cancer stem cells targeting EpCAM aptamer with a chemotherapeutic drug. Additionally, EpCAM antibody sensitizes chemoresistant myeloid leukemia to innate immune cells, and EpCAM peptide-primed dendritic cell vaccinations exhibit anti-tumor immunity in hepatocellular carcinoma cells.

Monoclonal antibody G8.8 was raised against glycoconjugates isolated from the TE-71 mouse thymic epithelial cell line2. Splenic cell suspensions were fused with X63-Ag8.653 cells and the resulting hybridomas were screened on frozen Balb/c thymus.
Antigen Distribution
EpCAM is expressed in many epithelial tissues from very early embryos to adult animals and is a cell surface marker on various stem and progenitor cells. EpCAM is also an important carcinoma marker highly expressed on a variety of carcinomas, including epithelial tumors and acute myeloid leukemia. EpCAM is enriched in the basolateral membrane of mouse and human intestinal epithelium and is localized to tight junctions, adherens junctions, and the lateral membranes of epithelial cells lining the intestines.
Ligand/Receptor
LAIR-1 (CD305) and LAIR-2 (CD306)
NCBI Gene Bank ID
UniProt.org
C99JW5
Research Area
Cell Adhesion
.
Immunology

Leinco Antibody Advisor

Powered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments.

Clone G8.8 is a rat monoclonal antibody specific for mouse EpCAM (CD326), extensively used to identify, isolate, or characterize epithelial cells in in vivo mouse studies. Its most common applications in mouse research include flow cytometry (FACS), immunohistochemistry (IHC), immunofluorescence (IF), immunocytochemistry (ICC), and immunoprecipitation.

Key uses of clone G8.8 in in vivo mouse studies:

  • Isolation and Purification: G8.8 is widely used to isolate and purify thymic epithelial cells and other EpCAM+ cell populations by flow cytometry or magnetic bead-based cell sorting.
  • Tissue and Cellular Marking: Application in IHC/IF enables detection and visualization of EpCAM+ epithelial cells in tissue sections, useful in studies of tissue development, regeneration, and pathologies like cancer.
  • Stem Cell and Lineage Tracing: By targeting EpCAM, G8.8 can be used in experiments tracing epithelial stem cell lineages or assessing changes in epithelial cell populations during disease or after genetic modification.
  • Tumor and Developmental Studies: Since EpCAM is expressed in many epithelial tumors, the antibody is used to study tumorigenesis, tumor progression, and epithelial cell biology in mouse models.

Technical details:

  • Host species: Rat
  • Recognizes: Mouse EpCAM, but not human or rat EpCAM
  • Common protocols: Used at concentrations of 2–5 ?g/ml for IHC/IF/ICC
  • Epitope: Raised against full-length native mouse EpCAM from the TE-71 thymic epithelial cell line.

Limitations:

  • The antibody does not cross-react with human or rat EpCAM, which is critical for interpretation in xenograft or humanized mouse studies.

In summary, G8.8 is a standard tool for marking, isolating, and characterizing mouse epithelial cells in vivo, especially in immunological, developmental, and cancer research.

The correct storage temperature for the sterile packaged clone G8.8 antibody is typically ?80°C upon arrival, unless otherwise specified by the manufacturer. Aliquot upon arrival and keep at ?80°C for long-term storage to preserve activity and sterility.

General guidelines for sterile antibodies (including monoclonal antibodies like G8.8):

  • Aliquot and store at ?80°C for long-term storage (several months or more).
  • Avoid repeated freeze-thaw cycles.
  • Some antibodies may be stored at 4°C for brief periods (a few days to weeks), but this is less suitable for long-term preservation.

If the antibody is supplied lyophilized (freeze-dried) and sterile, the packaging may permit storage at 2–8°C or at room temperature until reconstitution, but most working solutions should be stored at ?80°C whenever possible for maximum stability and to retain sterility.

If you are storing the antibody in a hospital sterile supply area, ensure the temperature does not exceed 25°C for dry, unopened packaged items, but this is not appropriate for laboratory antibody reagents.

Always check the manufacturer's data sheet for clone G8.8 for specific instructions, as formulations or preservatives can affect storage recommendations. If not available, ?80°C is the safest standard for most sterile monoclonal antibody clones.

The antibody G8.8 is widely recognized as an anti-EpCAM (epithelial cell adhesion molecule) antibody. In literature, several other antibodies and proteins are commonly used together with G8.8 for identification, sorting, or functional studies involving EpCAM-expressing cells. The choice of accompanying antibodies or proteins depends on the experimental context, but the most frequently co-used markers include:

  • CD44: Often co-stained with G8.8 to study cancer stem cells, as CD44 is a stem cell and adhesion marker.
  • CD24: Used in combination with G8.8 for further delineation of epithelial or stem cell subpopulations, especially in cancer research.
  • CD326 (EpCAM): G8.8 itself is an anti-EpCAM antibody, but other EpCAM antibodies (such as HEA125 or Ber-EP4 clones) are sometimes used for validation or in multi-color panels.
  • Cytokeratins (CKs): Antibodies to cytokeratins such as CK8, CK18, or CK19 are commonly used to confirm epithelial identity in conjunction with G8.8 labeling.
  • CD45: A pan-leukocyte marker used to exclude hematopoietic cells in flow cytometry, often paired with G8.8 to isolate non-hematopoietic, EpCAM-positive cells.
  • Other lineage exclusion markers: Including CD31 (endothelial), CD90 (mesenchymal), and others as relevant for the system under study.

Reporter proteins and detection systems (such as enzyme-conjugates or fluorescent secondary antibodies) are technically used with G8.8 in ELISA, flow cytometry, and microscopy applications. Additionally, proteins like Protein G are utilized for antibody purification and conjugation purposes.

Example applications in literature include:

  • Flow cytometry panels: G8.8 anti-EpCAM together with anti-CD44, anti-CD24, and anti-CD45 to identify and sort various cell populations.
  • Immunocytochemistry/Immunohistochemistry: Co-staining with cytokeratin antibodies to validate epithelial lineage.

In studies focusing on the ABCG5/G8 transporter complex (unrelated to G8.8/EpCAM), monoclonal antibodies such as 2E10 and 11F4 have been used to form stable complexes for biochemical and structural characterization. However, this context is distinct from the G8.8 anti-EpCAM antibody.

In summary: G8.8 (anti-EpCAM) is most commonly used with antibodies against CD44, CD24, cytokeratins, CD45, and sometimes additional epithelial or lineage markers concerning isolation and characterization of epithelial and cancer stem cells.

Clone G8.8 is a rat monoclonal antibody widely used for the detection and purification of mouse EpCAM (CD326), an epithelial cell adhesion molecule important in various biological and immunological contexts. Key findings and applications from scientific literature and product documentation include:

  • Species Specificity: G8.8 is specific to mouse EpCAM (CD326) and does not recognize the human or rat versions of the protein.
  • Key Applications:
    • Flow Cytometry (FACS): Used to identify and sort mouse epithelial cells and subpopulations, including a small subset of CD3+CD25+EpCAM+ splenic T lymphocytes.
    • Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC): Frequently recommended for marking epithelial cells in mouse tissues, with standard working concentrations suggested to start at 2–5?µg/mL for mouse samples.
    • Immunoprecipitation and Western Blot: Validated for these applications to detect EpCAM at ?40?kDa molecular weight in mouse samples.
  • Purification of Thymic Epithelial Cells: G8.8 has been used for isolating these cells, as documented in the scientific literature (e.g., PubMed IDs 20548034 and 17127749, referenced in technical documentation).
  • Epitope/Antigen Details: The immunogen for G8.8 is the full-length native EpCAM protein from the mouse TE-71 thymic epithelial cell line.
  • No Cross-Reactivity: G8.8 does not cross-react with other species’ EpCAM, an important characteristic for precise mouse-specific analyses.
  • Product and Repository Information: The hybridoma is available from the Developmental Studies Hybridoma Bank (DSHB), deposited by A.G. Farr (University of Washington).

Summary Table: G8.8 Clone—Key Scientific Insights

FeatureDetails/Findings
Target antigenMouse EpCAM (CD326)
Species reactivityMouse only
Notable non-reactivityHuman and rat EpCAM
Recommended applicationsFACS, IHC, IF, ICC, IP, Western blot
ImmunogenFull length native protein (mouse TE-71 cell line)
Key utilityDetects/purifies thymic and other epithelial cells; immune cell profiling
Notable studies/citationsUsed in studies isolating thymic epithelial cells (PMID: 20548034, 17127749)
Epitope location/sequenceNot specifically mapped

G8.8 is considered a reliable tool for mouse epithelial cell studies and immune cell profiling, particularly in thymic biology and immunology research. When referencing G8.8 in research, it is important to note its mouse specificity and acknowledge both the DSHB and the original contributor.

References & Citations

1. Huang L, Yang Y, Yang F, et al. Int J Mol Med. 42(4):1771-1785. 2018.
2. Farr A, Nelson A, Truex J, et al. J Histochem Cytochem. 39(5):645-653. 1991.
3. Li H, Hsu HC, Wu Q, et al. Nat Commun. 5:4259. 2014.
4. Wang J, Wang D, Chu K, et al. Nat Commun. 10(1):4966. 2019.
5. Martínez LE, Garcia G Jr, Contreras D, et al. J Virol. 94(9):e00067-20. 2020.
6. Petersen B, Wolf M, Austermann J, et al. EMBO J. 32(1):100-111. 2013.
7. Snitow M, Lu M, Cheng L, et al. Development. 143(20):3733-3741. 2016.
8. Kazakevych J, Denizot J, Liebert A, et al. Genome Biol. 21(1):64. 2020.
9. Maaser K, Borlak J. Br J Cancer. 99(10):1635-1643. 2008.
10. Kuan II, Liang KH, Wang YP, et al. Sci Rep. 7:41852. 2017.
11. Kuroki S, Maeda R, Yano M, et al. Stem Cell Reports. 15(2):424-438. 2020.
12. Papadopoulou AS, Dooley J, Linterman MA, et al. Nat Immunol. 13(2):181-187. 2011.
13. Goldman O, Han S, Sourisseau M, et al. Cell Stem Cell. 12(6):748-760. 2013.
14. Shim EJ, Bang BR, Kang SG, et al. J Immunol. 191(5):2764-2770. 2013.
15. de Jong JH, Rodermond HM, Zimberlin CD, et al. Sci Rep. 2:271. 2012.
16. Liu Z, Guo W, Zhang D, et al. Sci Rep. 6:39808. 2016.
17. Freire T, Zhang X, Dériaud E, et al. Blood. 116(18):3526-3536. 2010.
18. Naus S, Blanchet MR, Gossens K, et al. Am J Respir Crit Care Med. 181(12):1318-1328.2010.
19. Cook BD, Liu S, Evans T. Blood. 16;117(24):6489-6497. 2011.
20. Krishnamurthy B, Chee J, Jhala G et al. Diabetes. 61(2):425-435. 2012.
21. El-Zaatari M, Kao JY, Tessier A, et al. PLoS One. 8(3):e58935. 2013.
22. Magness ST, Puthoff BJ, Crissey MA, et al. Am J Physiol Gastrointest Liver Physiol.305(8):G542-551. 2013.
23. Tata PR, Mou H, Pardo-Saganta A, et al. Nature. 503(7475):218-223. 2013.
24. Fischedick G, Wu G, Adachi K, et al. Stem Cell Res. 13(2):300-315. 2014.
25. Velardi E, Tsai JJ, Holland AM, et al. J Exp Med. 211(12):2341-2349. 2014.
26. Clatworthy MR, Aronin CE, Mathews RJ, et al. Nat Med. 20(12):1458-1463. 2014.
27. Thelemann C, Eren RO, Coutaz M, et al. PLoS One. 9(1):e86844. 2014.
28. Walmsley GG, Rinkevich Y, Hu MS, et al. Tissue Eng Part C Methods. 21(3):314-321. 2015.
29. Xia H, Ren X, Bolte CS, et al. Am J Respir Cell Mol Biol. 52(5):611-621. 2015.
30. Goto Y, Lamichhane A, Kamioka M, et al. Sci Rep. 5:15918. 2015.
31. Satoh R, Kakugawa K, Yasuda T, et al. PLoS Genet. 12(1):e1005776. 2016.
32. Shi Y, Wu W, Chai Q, et al. Nat Commun. 7:12369. 2016.
33. Cuccarese MF, Dubach JM, Pfirschke C, et al. Nat Commun. 8:14293. 2017.
34. Yamaji M, Jishage M, Meyer C, et al. Nature. 543(7646):568-572. 2017.
35. Lim JS, Ibaseta A, Fischer MM, et al. Nature. 545(7654):360-364. 2017.
36. Lopes N, Vachon H, Marie J, et al. EMBO Mol Med. 9(6):835-851. 2017.
37. Nikolaidis NM, Noel JG, Pitstick LB, et al. Proc Natl Acad Sci U S A. 114(32):E6613-E6622.2017
38. Koh AS, Miller EL, Buenrostro JD, et al. Nat Immunol. 19(2):162-172. 2018.
39. Lopes N, Charaix J, Cédile O, et al. Nat Commun. 9(1):1262. 2018.
40. Moretti FA, Klapproth S, Ruppert R, et al. Elife. 7:e35816. 2018.
41. Thilakasiri P, Huynh J, Poh AR, et al. EMBO Mol Med. 11(4):e9539. 2019.
42. Glal D, Sudhakar JN, Lu HH, et al. Front Immunol. 9:2522. 2018.
43. Wang X, Yang L, Wang YC, et al. Cell Res. 30(12):1109-1126. 2020.
44. Giraud J, Foroutan M, Boubaker-Vitre J, et al. Transl Oncol. 14(2):101001. 2021.
45. Goga A, Yagabasan B, Herrmanns K, et al. Nat Commun. 12(1):3339. 2021.
46. Mauduit O, Aure MH, Delcroix V, et al. Cell Rep. 39(2):110663. 2022.
47. Ferreirinha P, Pinheiro RGR, Landry JJM, et al. Development. 149(10):dev200513. 2022.
Flow Cytometry
IF
IHC
Immunoprecipitation Protocol
General Western Blot Protocol

Certificate of Analysis

- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.